TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Ending Cash Balance (2020 - 2026)

Updated

TScan Therapeutics (TCRX) recorded Ending Cash Balance of $78.07 million in Q3 2026, down 55.3% from $174.54 million a year earlier and down 25.8% from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Ending Cash Balance (2020 - 2026) Analysis & Trends

For FY2025, TScan Therapeutics reported Ending Cash Balance of $157.44 million, down 14.3% from FY2024.

  • Annual Ending Cash Balance has a five-year compound annual growth rate of 34.8% (FY2020 to FY2025).
  • Across earlier years, Ending Cash Balance came in at $183.72 million in FY2024 (+32.8%), $138.39 million in FY2023 (+10.7%), $125.06 million in FY2022 (-24.9%) and $166.44 million in FY2021 (+370.3%).
  • The Q3 2026 figure is the lowest quarterly Ending Cash Balance since Q4 2020.
  • On a year-over-year basis, Ending Cash Balance has declined for four consecutive quarters, with an average decline of 10.8% over the last eight quarters.
  • Peak year-over-year performance for Ending Cash Balance in the last five years was growth of 370.3% in Q4 2021, against a decline of 55.3% in Q3 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $105.19 million (Q2 2026), $133.09 million (Q1 2026) and $157.44 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 16,287.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 4.89 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 16.91 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 10.77 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 9.65 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 6.44 Bn
9 Gsk 193.54 Bn 176.38 Bn - 3.88 Bn
10 TScan Therapeutics 18.87 Mn -434.83 Mn - 78.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 78.07 Mn
Jun 30, 2026 105.19 Mn
Mar 31, 2026 133.09 Mn
Dec 31, 2025 157.44 Mn
Sep 30, 2025 174.54 Mn
Jun 30, 2025 174.43 Mn
Mar 31, 2025 159.14 Mn
Dec 31, 2024 183.72 Mn
Sep 30, 2024 138.15 Mn
Jun 30, 2024 247.19 Mn
Mar 31, 2024 145.54 Mn
Dec 31, 2023 138.39 Mn
Sep 30, 2023 160.22 Mn
Jun 30, 2023 213.87 Mn
Mar 31, 2023 100.64 Mn
Dec 31, 2022 125.06 Mn
Sep 30, 2022 142.34 Mn
Jun 30, 2022 130.64 Mn
Mar 31, 2022 145.87 Mn
Dec 31, 2021 166.44 Mn
API Access

TScan Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=TCRX&period=max&api_key=YOUR_API_KEY